Tag:
NeuroPhage Pharmaceuticals
Latest Headlines
Latest Headlines
NeuroPhage pockets $12.4M round for Alzheimer's work
Cambridge, MA-based NeuroPhage Pharmaceuticals has nabbed $12.4 million in new venture funding to back a Phase I trial of its lead therapy for Alzheimer's. Two new investors, MerieuxDeveloppement and
